Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age45-74
SponsorAstraZeneca
About this trial
Observational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Hospital das Clínicas da Faculdade de Medicina de Botucatu (HCFMB)18618-686, BotucatuSão Paulo, Brazil
Sponsors and collaborators
AstraZeneca
Lead sponsor
Source ClinicalTrials.gov